Published in Clin J Am Soc Nephrol on July 29, 2010
Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med (2014) 5.01
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int (2015) 1.50
Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol (2014) 1.24
Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int (2011) 1.13
Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2012) 1.06
Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol (2014) 1.03
Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant (2011) 1.00
Identification of Biomarkers for PKD1 Using Urinary Exosomes. J Am Soc Nephrol (2014) 0.96
Clinical and molecular insights into tuberous sclerosis complex renal disease. Pediatr Nephrol (2010) 0.87
Tuberous sclerosis complex: the past and the future. Pediatr Nephrol (2014) 0.86
ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. Am J Kidney Dis (2014) 0.84
Current management of autosomal dominant polycystic kidney disease. World J Nephrol (2015) 0.82
Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry. BMC Nephrol (2013) 0.80
Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014). Popul Health Metr (2017) 0.78
The Danish Nephrology Registry. Clin Epidemiol (2016) 0.75
End-Stage Kidney Failure in Oman: An Analysis of Registry Data with an Emphasis on Congenital and Inherited Renal Diseases. Int J Nephrol (2017) 0.75
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
Polycystic kidney disease. N Engl J Med (2004) 5.73
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int (2009) 3.66
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet (1999) 3.32
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl (1957) 2.86
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis (1983) 2.22
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2006) 2.21
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81
Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int (2003) 1.65
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol (2002) 1.63
Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant (2003) 1.56
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol (2004) 1.20
The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant (2009) 1.19
Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol (2006) 1.15
Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant (2004) 1.08
Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens (2004) 1.07
Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia (2007) 1.05
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int (2005) 1.02
Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol (1994) 0.97
Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark. Kidney Int (2006) 0.91
Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2006) 0.89
Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease. Ren Fail (2007) 0.85
Progress in blood pressure control in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 0.85
Predicting future trends in the number of patients on renal replacement therapy in Denmark. Nephrol Dial Transplant (1997) 0.78
Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation (2004) 3.71
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease. Kidney Int (2013) 2.08
New-onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol (2010) 1.53
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant (2011) 1.44
Factors influencing the decision to start drug treatment in hypertension. A questionnaire study comparing general practitioners and hypertension specialists in Denmark. Blood Press (2006) 1.40
Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int (2003) 1.29
Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant (2007) 1.23
Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol (2008) 1.13
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. Am J Kidney Dis (2008) 1.08
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.06
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int (2005) 1.02
Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. Kidney Int (2012) 1.01
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? Diabetologia (2014) 0.98
Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med (2010) 0.98
Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trial. PLoS One (2012) 0.96
Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study. Scand J Infect Dis (2012) 0.93
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2009) 0.89
Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am J Nephrol (2007) 0.87
Kidney transplantation improves arterial function measured by pulse wave analysis and endothelium-independent dilatation in uraemic patients despite deterioration of glucose metabolism. Nephrol Dial Transplant (2010) 0.86
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease. Nephrol Dial Transplant (2009) 0.86
Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease. Am J Nephrol (2006) 0.85
Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study. PLoS One (2013) 0.84
Increased urinary orosomucoid excretion is not related to impaired renal function in patients with type 2 diabetes. J Diabetes Complications (2008) 0.84
Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5. Nephrol Dial Transplant (2008) 0.83
Pre-diabetes and arterial stiffness in uraemic patients. Nephrol Dial Transplant (2009) 0.83
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study. PLoS One (2011) 0.83
Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. BMC Nephrol (2012) 0.83
Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. Clin J Am Soc Nephrol (2012) 0.82
Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up. J Diabetes Complications (2013) 0.81
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors? Expert Rev Neurother (2009) 0.81
Elevated third-trimester haemoglobin A 1c predicts preterm delivery in type 1 diabetes. J Diabetes Complications (2008) 0.81
Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats. Am J Physiol Heart Circ Physiol (2003) 0.80
Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol (2002) 0.80
Last Word on Point:Counterpoint: Sympathetic nervous activity does/does not influence cerebral blood flow. J Appl Physiol (1985) (2008) 0.79
Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J Diabetes Complications (2007) 0.79
Plasma adiponectin before and after kidney transplantation. Transpl Int (2012) 0.79
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. Eur J Clin Pharmacol (2005) 0.79
The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats. APMIS (2004) 0.79
Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl Int (2013) 0.78
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol (2008) 0.78
Ambulatory arterial stiffness index in chronic kidney disease stage 2-5. Reproducibility and relationship with pulse wave parameters and kidney function. Scand J Clin Lab Invest (2012) 0.78
Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis. Cardiovasc Res (2004) 0.78
High levels of mannose-binding lectin are associated with lower pulse wave velocity in uraemic patients. BMC Nephrol (2014) 0.78
[Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients]. Ugeskr Laeger (2002) 0.78
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis (2003) 0.78
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease. J Clin Endocrinol Metab (2014) 0.78
Blood pressure response to conventional and low-dose enalapril in chronic renal failure. Br J Clin Pharmacol (2003) 0.77
High incidence of secondary hypertension in patients referred for renal denervation--the Copenhagen experience. Blood Press (2014) 0.77
Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy. Int J Cancer (2014) 0.77
Blood pressure lowering in acute ischaemic stroke: an update on the role of angiotensin receptor blockers. J Hypertens (2007) 0.77
Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease. Nephrol Dial Transplant (2013) 0.77
Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension. J Clin Endocrinol Metab (2005) 0.77
Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. Nephron Clin Pract (2010) 0.76
Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat. J Renin Angiotensin Aldosterone Syst (2002) 0.76
The management of elevated blood pressure in acute stroke: preferential use of angiotensin II receptor antagonists? J Hypertens (2004) 0.75
[New-onset diabetes mellitus after kidney transplantation]. Ugeskr Laeger (2012) 0.75
[Continuous glucose monitoring of patients with type 1- and type 2 diabetes on haemodialysis]. Ugeskr Laeger (2020) 0.75
Glycaemic control in diabetic patients during hospital admission is not optimal. Dan Med Bull (2011) 0.75
[Hypertension and the brain]. Ugeskr Laeger (2009) 0.75
Claus Brun (1914-2014). Nephrol Dial Transplant (2014) 0.75
Long-term graft and patient survival following renal transplantation in diabetic patients. Scand J Urol Nephrol (2006) 0.75
[Hypertension and renal disease]. Ugeskr Laeger (2009) 0.75
The Nephrocare project: referral, patient case-mix, follow-up and quality of renal care in Nordic renal centres. Scand J Urol Nephrol (2009) 0.75
Transendothelial lipoprotein exchange and microalbuminuria. Cardiovasc Res (2004) 0.75
[In Process Citation]. Ugeskr Laeger (2014) 0.75
Transvascular lipoprotein transport in patients with chronic renal disease. Kidney Int (2004) 0.75
Danish guidelines for lipid-lowering treatment in patients with chronic renal failure. Dan Med J (2014) 0.75
[Secondary prevention of stroke with effective antihypertensive treatment]. Ugeskr Laeger (2013) 0.75
Can value for money be improved by changing the sequence of our donor work-up in the living kidney donor programme? Transpl Int (2009) 0.75
Cardiac autonomic neuropathy in patients with uraemia is not related to pre-diabetes. Dan Med Bull (2011) 0.75
Drug Dosing and Estimated Renal Function - Any Step Forward from Effersoe? Nephron (2017) 0.75
Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation. Nephrol Dial Transplant (2007) 0.75
[Renoprotection and blockade of the renin-angiotensin system: What shall we believe?]. Ugeskr Laeger (2006) 0.75